Here you will find articles and links to research and other good reads

Guy's and St Thomas' NHS Foundation Trust 

23 June at 16:01 · 

Our patients are the first in the country to receive a revolutionary treatment for chronic obstructive pulmonary disease (COPD).

The new injection, developed by King's College London, is called dupilumab. It can be self-administered like an insulin pen and provides additional therapy to prevent flare ups of COPD – a progressive, long-term lung disease that makes it hard to breathe.

The treatment, approved by National Institute for Health and Care Excellence earlier this year, works by reducing inflammation in the body.

Patrick Regan, 67, was the first person to receive the new treatment at St Thomas’ Hospital today.

He said: “I was happy to have it, anything to make me feel a bit better and breathing better. COPD affects me a lot and stops me doing things I want to do like walking and going out with my kids and grandkids. That’s one of the most important reasons to get this new medication so I can do more things with the kids.”

Dr Amy Dewar, a consultant in integrated respiratory medicine and lead for COPD at Guy's and St Thomas', said: “This is very much a new avenue of treatment for COPD and will make a truly meaningful impact on patients to reduce admissions and flare ups of their condition.”

To read the full story, visit https://ow.ly/J2UO50ZfRkv

UPDATE: Our healthcare teams will decide if this treatment is appropriate for patients having care at Guy's and St Thomas' hospitals. For people being treated elsewhere, our Trust is not currently taking referrals for the new treatment. Integrated Care Boards (ICBs) are working to make it available to eligible patients across the country as soon as possible.

#COPDTreatment #RespiratoryHealth #ChronicObstructivePulmonaryDisease #Dupilumab #LungHealth